Fosine

Therapeutic Group

Indication Dosage

Miltefosine is a medication indicated for the treatment of visceral leishmaniasis (kala-azar) in pediatric and adult patients. This oral medication is specifically approved for use in regions where the disease is endemic and caused by Leishmania donovani or Leishmania infantum parasites. It serves as a valuable therapeutic option in the management of this potentially life-threatening parasitic infection.

Visceral Leishmaniasis, Adjunct Therapy In Colorectal Cancer And Metastatic Breast Cancer: 

• Adults: 50-150 Mg Daily For 28 Days.

Content

Pregnancy

Contraindicated In Pregnancy.

Stability

Contra Indications

Precautions

Lactation

Side Effects